Back
MaxCyte 10K Form
Buy
63
MXCT
MaxCyte
Last Price:
$2.31
Seasonality Move:
42.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MXCT News And Ratings
See the #1 stock for the next 7 days that we like better than MXCT
MXCT Financial Statistics
Sales & Book Value
| Annual Sales: | $38.6M |
|---|---|
| Cash Flow: | $-15.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.88 |
| Price / Book: | 1.16 |
Profitability
| EPS (TTM): | -0.40000 |
|---|---|
| Net Income (TTM): | $-41.8M |
| Gross Margin: | $31.5M |
| Return on Equity: | -19.59% |
| Return on Assets: | -17.02% |
MaxCyte Earnings Forecast
Key MaxCyte Financial Ratios
-
The Gross Profit Margin over the past 13 years for MXCT is 81.62%.
-
The Selling, General & Administrative Expenses for MXCT have been equal to 145.89% of Gross Profit Margin.
-
The Research & Development expenses have been 57.54% of Revenue.
-
The Net Earning history of MXCT is -106.29% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 4 years.
MaxCyte Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | MXCT |
| Website: | maxcyte.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.23 |
| Quick Ratio: | 11.29 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |